Healthcare -
Biotechnology - NASDAQ - US
$ 2.77
-4.81 %
$ 4.8 M
Market Cap
-0.28
P/E
PHIO - ACCOUNTS PAYABLE
Accounts Payable PHIO - Phio Pharmaceuticals Corp.
657 K
LAST VALUE
52.37%
2 YEAR CAGR
3.62%
5 YEAR CAGR
14.96%
10 YEAR CAGR